High serum parathyroid hormone and calcium are risk factors for hypertension in Japanese patients

  • Yagi Shusuke
    Department of Cardiovascular Medicine, The University of Tokushima Graduate School of Health Biosciences, Tokushima 770-8503, Japan
  • Aihara Ken-ichi
    Department of Medicine and Bioregulatory Sciences, The University of Tokushima Graduate School of Health Biosciences, Tokushima 770-8503, Japan
  • Kondo Takeshi
    Department of Medicine and Bioregulatory Sciences, The University of Tokushima Graduate School of Health Biosciences, Tokushima 770-8503, Japan
  • Endo Itsuro
    Department of Medicine and Bioregulatory Sciences, The University of Tokushima Graduate School of Health Biosciences, Tokushima 770-8503, Japan
  • Hotchi Junko
    Department of Cardiovascular Medicine, The University of Tokushima Graduate School of Health Biosciences, Tokushima 770-8503, Japan
  • Ise Takayuki
    Department of Cardiovascular Medicine, The University of Tokushima Graduate School of Health Biosciences, Tokushima 770-8503, Japan
  • Iwase Takashi
    Department of Cardiovascular Medicine, The University of Tokushima Graduate School of Health Biosciences, Tokushima 770-8503, Japan
  • Akaike Masashi
    Department of Medical Education, The University of Tokushima Graduate School of Health Biosciences, Tokushima 770-8503, Japan
  • Matsumoto Toshio
    Department of Medicine and Bioregulatory Sciences, The University of Tokushima Graduate School of Health Biosciences, Tokushima 770-8503, Japan
  • Sata Masataka
    Department of Cardiovascular Medicine, The University of Tokushima Graduate School of Health Biosciences, Tokushima 770-8503, Japan

Search this article

Abstract

Excess parathyroid hormone (PTH), known as primary hyperparathyroidism (pHPT), results in hypercalcemia and bone loss. Recent studies have shown that PTH is associated with the occurrence of hypertension in Western countries; however, controversy remains regarding high serum levels of PTH and calcium as risk factors for hypertension in Japanese patients. We retrospectively enrolled 114 consecutive Japanese patients who visited our hospital for examination and treatment of hypercalcemia and/or hypertension with serum calcium levels ≥9.8 mg/dL. To estimate the prevalence of hypertension, the patients were categorized according to calcium levels into hypercalcemic (10.2-13.4 mg/dL) and normocalcemic (9.8-10.1 mg/dL) groups, which were further categorized into high PTH (50-440 pg/mL) and low PTH (8-49 pg/mL) groups. The prevalence of hypertension was higher in patients with hypercalcemia than in patients with normocalcemia in both the high and low PTH groups. The prevalence of hypertension was higher in patients with high serum PTH levels than in patients with low serum PTH levels in both the hypercalcemic and normocalcemic groups. Logistic multiple regression analysis determined that serum calcium (P < 0.05) and PTH (P < 0.01) levels were positive contributors to hypertension. In conclusion, high serum levels of PTH and calcium are risk factors for hypertension in Japanese patients.

Journal

  • Endocrine Journal

    Endocrine Journal 61 (7), 727-733, 2014

    The Japan Endocrine Society

References(20)*help

See more

Related Projects

See more

Details

Report a problem

Back to top